Company / R&D per Share
Oric Pharmaceuticals, Inc. R&D per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.25
FY2025
5-year range
$1.25 / $1.66
FY2021-FY2025
Trend
-23.5%
vs FY2024
Sector context
#136 of 208
Health Care
What the data says
At $1.25, Oric Pharmaceuticals, Inc.'s r&d per share ranks #136 of 208 in the Health Care sector. R&D per Share has fluctuated over the past 8 years, ranging from $1.25 in FY2025 to $12.03 in FY2019.
Based on SEC 10-K filings.
1.25 in FY2025 with a 5-year CAGR of -5.2%.
Declined from $1.66 to $1.25 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- -7.0%
- 5-Year CAGR
- -5.2%
- 10-Year CAGR
- -
Sector benchmark
#136 of 208 in Health CareTop 65% of 208This company $1.25 Sector average $28.82
▼
-95.7% below sector average
Key checks
Key Insights
- In FY2025, r&d per share decreased 23.5% year-over-year.
- Ranks #136 out of 208 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2019.
Company context
Key Data Points
- Altman Z-Score 5.96 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.25 | -23.5% |
| FY2024 | $1.64 | -1.2% |
| FY2023 | $1.66 | +6.4% |
| FY2022 | $1.56 | +3.8% |
| FY2021 | $1.50 | -8.5% |
| FY2020 | $1.64 | -86.4% |
| FY2019 | $12.03 | +9.6% |
| FY2018 | $10.97 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026